Target therapy of kidney cancer: what is the treatment, its advantages

Currently, the standard for the treatment of renal oncology is still a surgical operation, but only 23% of patients after it live more than five years. Realization of hormonal treatment, chemotherapy.irradiation does not help improve the outcome of treatment. Irradiation is used only for patients with extensive metastases to the brain or to reduce the intensity of pain. Chemotherapy has many side effects. Against this background, targeted therapy for kidney cancer involves the organization of the search for and destruction of malignant tumor cells. In this case, there is no negative effect on healthy cells, which is typical for chemotherapy.

Recently, cardinally changed approaches to the treatment of malignant neoplasms in the kidneys. Patients have a real chance of normalization and an increase in life expectancy through the use of new drugs. Target treatment involves affecting specific links in the formation of a tumor. When exposed to molecules and cells that play a major role in the growth and division of tumors, drugs are able to disable the pathological process and slow the progression of the disease. Such influence is targeted on pathological cells and does not have side effects for healthy cells of the human body.

This is important! Thamoxifen, used for the purpose of blocking estrogens in the organization of treatment of breast oncology, can be considered the founder of targeted therapy. Scientists have shown that stimulation of the operation of estrogen receptors blocks the growth of the tumor.

The main advantages of using targeted therapy

In accordance with the research of specialists, targeted drugs in renal oncology are much more effective than immunotherapy in their effectiveness. In addition, the human body is better tolerated by their effects.

It is important to take into account also the form of the use of medicines, which does not require hospitalization during treatment.

No additional treatment is required to use targeted medications, such as increased hemoglobin concentration in the blood, stimulation of leukopoiesis, antiemetic treatment, and the like.

The number of officially known side effects of treatment does not exceed 10% and most of them are considered reversible. If desired, side effects can be quenched by adjusting the dosage or making a short break in the course of treatment.

Thanks to targeted medicines, the survival rate of patients with renal oncology doubled, and the progression of metastatic lesions does not develop.

This is important! Monitoring elderly patients suggests that targeted drugs do not pose a risk to people over seventy years of age, which is of great importance in treatment, because older people are more often than not affected by oncology.

Now known many officially registered medications that are effective in the formation of tumors of different histological species. But it is important to consider that targeted therapy is not a full-fledged alternative to a surgical operation. They only allow to improve the results of treatment in general, but should not be considered their primary means of treating cancer and getting a 100% result. At the moment, the use of these drugs in oncology is considered a chance to help increase the life expectancy of people without deteriorating its quality.

Target medicines act on tumor cells and do not have a toxic effect on cancer cells untouched. In connection with this, treatment is considered to be the most safe and effective. It is often realized simultaneously with other methods or as monotherapy. In addition, this method becomes an alternative if it is impossible to organize chemotherapy or other treatment, as well as if there are contraindications to the operation.

Like the article? Share with friends and acquaintances: